pe
pep-05352 v1 CC-BY-SA-4.0

Defensin anticancer peptide

A lab-made peptide being studied for its potential to fight cancer cells; experimental, not an approved drug.

statuscomputed targetANTICANCER length48 aa refs1
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.543
avg pLDDT66.7
ranking score0.642
STRUCTURE · PEP-05352 × ANTICANCER
ranking0.642
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence48 aa
15101520253035404548
FTCDVLSAEGGFRGVS IKLNHAACAAHCLYLK KRGGYCNDKAVCVCRK
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.6423924565315247 boltz-2
3-letter notation
Phe-Thr-Cys-Asp-Val-Leu-Ser-Ala-Glu-Gly-Gly-Phe-Arg-Gly-Val-Ser-Ile-Lys-Leu-Asn-His-Ala-Ala-Cys-Ala-Ala-His-Cys-Leu-Tyr-Leu-Lys-Lys-Arg-Gly-Gly-Tyr-Cys-Asn-Asp-Lys-Ala-Val-Cys-Val-Cys-Arg-Lys
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Defensin anticancer peptide (pep-05352, v1). PeptideModel. https://peptidemodel.com/card/pep-05352
@peptide{pep05352,
  sequence = {FTCDVLSAEGGFRGVSIKLNHAACAAHCLYLKKRGGYCNDKAVCVCRK},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 1 by signal overlap
references 1 papers
[1]
Tribolium castaneum defensins are primarily active against Gram-positive bacteria
Tonk M; Knorr E; Cabezas-Cruz A; Valdés J; Kollewe C; Vilcinskas A Journal of Invertebrate Pathology 2015
source scaffold
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use